Clinical decision-making

临床决策
  • 文章类型: Journal Article
    背景:必须全面,正确地解释指南,以规范临床过程。然而,这一过程具有挑战性,需要口译员具有医学背景和资格。在这项研究中,评估了ChatGPT3.5回答与2019年重症急性胰腺炎指南相关的临床问题的准确性.
    结果:使用2019年重症急性胰腺炎指南进行了一项观察性研究。该研究比较了ChatGPT3.5在英语和汉语中的准确性,发现它在英语中(71%)比在汉语中(59%)更准确(P值:0.203)。此外,该研究评估了ChatGPT3.5回答简答题与真/假问题的准确性,发现它回答简答题(76%)比回答真/假问题(60%)更准确(P值:0.405).
    结论:对于重症急性胰腺炎的临床医生,ChatGPT3.5可能具有潜在价值。然而,临床决策不应过分依赖它。
    BACKGROUND: Guidelines must be interpreted comprehensively and correctly to standardize the clinical process. However, this process is challenging and requires interpreters to have a medical background and qualifications. In this study, the accuracy of ChatGPT3.5 in answering clinical questions related to the 2019 guidelines for severe acute pancreatitis was evaluated.
    RESULTS: An observational study was conducted using the 2019 guidelines for severe acute pancreatitis. The study compared the accuracy of ChatGPT3.5 in English versus Chinese and found that it was more accurate in English (71%) than in Chinese (59%) (P value: 0.203). Additionally, the study assessed the accuracy of ChatGPT3.5 in answering short-answer questions versus true/false questions and found that it was more accurate in answering short-answer questions (76%) than in answering true/false questions (60%) (P value: 0.405).
    CONCLUSIONS: For clinicians managing severe acute pancreatitis, ChatGPT3.5 may have potential value. However, it should not be relied upon excessively for clinical decision making.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:手术和放疗是前列腺癌(PCa)的主要非保守治疗方法。然而,由于标准不明确,在这些治疗方式之间进行个性化治疗方案具有挑战性.我们开发了一种基于人工智能(AI)的模型,可以识别局部PCa患者,他们将从放疗或手术中受益更多。从而提供个性化的临床决策。
    方法:来自连续接受放疗或手术的局部PCa患者的数据,并在12个监测记录中记录了完整的临床病理变量和随访结果,流行病学,和最终结果数据库进行了分析。来自7个注册中心的患者以9:1的比例随机分配到训练(TD)和内部验证数据集(IVD)。剩余的5个注册表构成外部验证数据集(EVD)。TD分为训练放射治疗(TRD)和训练手术(TSD)数据集,和IVD分为内放疗(IRD)和内手术(ISD)数据集。采用TRD和TSD对6个放疗和手术模型进行训练,预测放疗生存概率(RSP)和手术生存概率(SSP),分别。选择IRD和ISD上具有最高一致性指数(C指数)的模型来形成最终的治疗建议模型(FTR)。FTR建议基于RSP和SSP之间的较高值。Kaplan-Meier曲线用于接受推荐治疗(一致组)和非推荐治疗(不一致组)的患者,使用对数秩检验进行比较。
    结果:该研究包括118236名患者,分类为TD(TRD:44621;TSD:41500),IVD(IRD:4949;ISD:4621),和EVD(22545)。放疗和手术模型均可准确预测RSP和SSP(C指数分别为0.735-0.787和0.769-0.797)。一致组生存率高于不一致组,特别是在不适合主动监测的患者中(P<0.001)。
    结论:FTR可以准确识别局部PCa患者,这些患者可以从放疗或手术中获益更多。为临床医生提供有效的人工智能工具,在这两种治疗方法之间做出明智的选择。
    BACKGROUND: Surgery and radiotherapy are primary nonconservative treatments for prostate cancer (PCa). However, personalizing treatment options between these treatment modalities is challenging due to unclear criteria. We developed an artificial intelligence (AI)-based model that can identify patients with localized PCa who would benefit more from either radiotherapy or surgery, thereby providing personalized clinical decision-making.
    METHODS: Data from consecutive patients with localized PCa who received radiotherapy or surgery with complete records of clinicopathological variables and follow-up results in 12 registries of the Surveillance, Epidemiology, and End Results database were analyzed. Patients from 7 registries were randomly assigned to training (TD) and internal validation datasets (IVD) at a 9:1 ratio. The remaining 5 registries constituted the external validation dataset (EVD). TD was divided into training-radiotherapy (TRD) and training-surgery (TSD) datasets, and IVD was divided into internal-radiotherapy (IRD) and internal-surgery (ISD) datasets. Six models for radiotherapy and surgery were trained using TRD and TSD to predict radiotherapy survival probability (RSP) and surgery survival probability (SSP), respectively. The models with the highest concordance index (C-index) on IRD and ISD were chosen to form the final treatment recommendation model (FTR). FTR recommendations were based on the higher value between RSP and SSP. Kaplan-Meier curves were generated for patients receiving recommended (consistent group) and nonrecommended treatments (inconsistent group), which were compared using the log-rank test.
    RESULTS: The study included 118 236 patients, categorized into TD (TRD: 44 621; TSD: 41 500), IVD (IRD: 4949; ISD: 4621), and EVD (22 545). Both radiotherapy and surgery models accurately predicted RSP and SSP (C-index: 0.735-0.787 and 0.769-0.797, respectively). The consistent group exhibited higher survival rates than the inconsistent group, particularly among patients not suitable for active surveillance (P < .001).
    CONCLUSIONS: FTR accurately identifies patients with localized PCa who would benefit more from either radiotherapy or surgery, offering clinicians an effective AI tool to make informed choices between these 2 treatments.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Case Reports
    目的:由肺栓塞(PE)引起的心脏骤停(CA)溶栓过程中的脑血管事件是一种危及生命的疾病。然而,在PE诱导的CA中,脑血管事件和溶栓治疗之间的平衡仍然是一个巨大的挑战.
    方法:在本研究中,我们报道了3例独特病例,涉及PE诱导的CA溶栓治疗中脑血管事件的主要关注点.
    结果:病例1中的患者在CPR期间接受溶栓治疗,并最终在神经功能上完好无损地出院。病例2患者接受延迟溶栓治疗,最终死亡。病例3中的患者由于动脉下血肿的并发症而禁忌溶栓,并在几天内死亡。
    结论:我们的病例系列重点介绍了在PE诱发的CA患者进行溶栓治疗前考虑的三种建议方法:(1)延长复苏时间,(2)及时给予溶栓,(3)排除脑血管事件。
    OBJECTIVE: Cerebrovascular events during thrombolysis in cardiac arrest (CA) caused by pulmonary embolism (PE) is a life-threatening condition. However, the balance between cerebrovascular events and thrombolytic therapy in PE-induced CA remains a great challenge.
    METHODS: In this study, we reported three unique cases regarding main concerns surrounding cerebrovascular events in thrombolytic therapy in PE-induced CA.
    RESULTS: The patient in the case 1 treated with thrombolysis during CPR and finally discharged neurologically intact. The patient in the case 2 received delayed thrombolysis and died eventually. The patient in the case 3 was contraindicated to thrombolysis due to the complication of subarachioid hemorrahage and died within days.
    CONCLUSIONS: Our case series highlights three proposed approaches to consider before administering thrombolysis as a treatment option in PE-induced CA patients: (1) prolonging the resuscitation, (2) administering thrombolysis promptly, and (3) ruling out cerebrovascular events.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    Anterior diastema is a common esthetic defect in China. The general treatment for a patient with diastemata, including orthodontics and direct and indirect restorations, is a multidisciplinary clinical procedure covering the orthodontics, operative dentistry, general dentistry, and prosthodontics department. Given the diversity of departments and the complex etiology of this defect, decision-making regarding the closing methods and time selection is undefined and unintegrated, which makes the long-term stability of closure unpredictable. This article proposed an etiology-based decision tree with actual measurement of diastemata width for diastemata closure. The decisional steps include classifying the etiological factors based on patients\' medical history and clinical manifestation to evaluate the stability of diastemata. After maintaining the stability of diastemata, contemporary and multidisciplinary treatment plans were selected in accordance with the measured width of diastemata and patients\' cosmetic psychology, economics, and available time. These decision trees focus on the challenges of collaboration among dental departments, propose an objective and efficient ways for connections, and promote efficient and effective diastemata closure.
    前牙牙间隙是一种常见的牙齿缺陷。临床常用关闭前牙牙间隙方案包括正畸治疗、直接修复以及间接修复等,是一项可能同时涉及正畸科、牙体牙髓科、修复科、全科以及牙周科等口腔门诊多科室合作的诊疗项目。由于当前我国口腔门诊普遍存在的分科过细、跨科室合作效率低,以及牙间隙的病因繁杂,使得临床跨科室合作关闭牙间隙时如何选择最佳治疗时机与合理方案尚缺乏清晰的诊疗思路,最终将影响关闭前牙牙间隙的疾病诊治效能和疗效。为此,本文推荐了一套基于病因诊断与牙间隙几何量实测值进行分类分级来关闭前牙牙间隙的三个序列临床决策树。该套决策树通过患者病史和临床检查结果进行病因归类,并判断牙间隙的稳定性,再进一步依据牙间隙几何量实测值、患者的求美心理评估、诊疗费用与时间成本等,合理选择相应的口腔门诊跨科室联合治疗方案,实现牙间隙的精准分类诊疗。本决策树针对前牙牙间隙跨科室合作难点,提供了客观高效的决策拐点,有助于进一步提高工作效率,提升关闭前牙牙间隙的疗效。.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:尿素氮与肌酐(BUN/Cr)比值与急性缺血性卒中(AIS)早期神经功能恶化有关。然而,BUN/Cr比值对AIS预后的预测价值尚不清楚.因此,我们评估了BUN/Cr比值与AIS患者3个月预后之间的相关性,进一步测试它们的剂量-反应关系。
    方法:这项回顾性队列研究纳入了2013年1月1日至2022年5月31日期间收治的AIS患者。不良临床结果定义为3个月改良Rankin量表(mRS)>2。Cox比例HR用于评估BUN/Cr比率与3个月结局之间的相关性。进行了限制性三次样条和稳健的局部加权回归分析,以确定BUN/Cr比率与3个月结局之间的剂量反应关系。
    结果:本研究共纳入4952例合格患者。根据BUN/Cr比率的三元率将患者分为三组(T1,<0.071;T2,0.071-0.093;T3,>0.093)。在对人口统计学和临床特征进行逻辑回归校正后,研究发现,在AIS患者中,BUN/Cr比值与3个月预后独立相关.受限三次样条和局部回归平滑散点图显示,AIS患者的BUN/Cr比值与3个月预后之间存在很强的剂量反应关系。
    结论:在AIS患者中观察到BUN/Cr比值与3个月预后之间的剂量-反应关系,提示BUN/Cr比值可作为AIS预后的可靠预测指标。
    OBJECTIVE: The blood urea nitrogen to creatinine (BUN/Cr) ratio is associated with early neurological deterioration in acute ischaemic stroke (AIS). However, the predictive value of the BUN/Cr ratio for the AIS prognosis remains unclear. Therefore, we evaluated the correlation between the BUN/Cr ratio and the 3-month outcome in patients with AIS, further testing their dose-response relationship.
    METHODS: This retrospective cohort study enrolled patients with AIS who were admitted between 1 January 2013 and 31 May 2022. Poor clinical outcome was defined as 3-month Modified Rankin Scale (mRS) >2. Cox proportional HR was used to evaluate the correlation between the BUN/Cr ratio and 3-month outcome. Restricted cubic spline and robust locally weighted regression analyses were conducted to determine the dose-response relationship between the BUN/Cr ratio and the 3-month outcome.
    RESULTS: A total of 4952 eligible patients were included in the study. The patients were divided into three groups according to the tertiles of BUN/Cr ratio (T1, <0.071; T2, 0.071-0.093; and T3, >0.093). After logistic regression adjustment for demographic and clinical characteristics, the BUN/Cr ratio was found to be independently associated with the 3-month outcome in patients with AIS. The restricted cubic spline and locally regression smoothing scatterplot graph showed a strong dose-response relationship between the BUN/Cr ratio and the 3-month outcome in patients with AIS.
    CONCLUSIONS: A dose-response relationship was observed between the BUN/Cr ratio and the 3-month outcome in patients with AIS, suggesting that the BUN/Cr ratio could serve as a reliable predictor for the AIS prognosis.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    我们开发了一种可解释的机器学习算法,可以前瞻性地预测老年危重病人在重症监护病房(ICU)期间的血小板减少症风险。最终帮助临床决策和改善患者护理。回顾性分析2012年至2021年东阳市人民医院ICU收治的2286例老年患者的手术资料。开发了集成算法,并使用了四种机器学习算法。选定的特征包括常见的人口统计数据,生化指标,和生命体征。使用最小绝对收缩和选择算子和随机森林算法选择了八个关键变量。18.2%的老年患者术后发生血小板减少,死亡率较高。C5.0模型表现出最好的性能,接收器工作特性曲线下的面积接近0.85,具有无与伦比的精度,精度,特异性,召回,和平衡准确度得分分别为0.88、0.98、0.89、0.98和0.85。支持向量机模型在预测血小板减少严重程度方面表现优异,在MIMIC数据库中显示0.80的准确率。因此,我们的基于机器学习的模型在有效预测老年ICU患者术后血小板减少的风险和严重程度方面具有相当大的潜力,以便更好的临床决策和患者护理.
    We developed an interpretable machine learning algorithm that prospectively predicts the risk of thrombocytopenia in older critically ill patients during their stay in the intensive care unit (ICU), ultimately aiding clinical decision-making and improving patient care. Data from 2286 geriatric patients who underwent surgery and were admitted to the ICU of Dongyang People\'s Hospital between 2012 and 2021 were retrospectively analyzed. Integrated algorithms were developed, and four machine-learning algorithms were used. Selected characteristics included common demographic data, biochemical indicators, and vital signs. Eight key variables were selected using the Least Absolute Shrinkage and Selection Operator and Random Forest Algorithm. Thrombocytopenia occurred in 18.2% of postoperative geriatric patients, with a higher mortality rate. The C5.0 model showed the best performance, with an area under the receiver operating characteristic curve close to 0.85, along with unparalleled accuracy, precision, specificity, recall, and balanced accuracy scores of 0.88, 0.98, 0.89, 0.98, and 0.85, respectively. The support vector machine model excelled at predictively assessing thrombocytopenia severity, demonstrating an accuracy rate of 0.80 in the MIMIC database. Thus, our machine learning-based models have considerable potential in effectively predicting the risk and severity of postoperative thrombocytopenia in geriatric ICU patients for better clinical decision-making and patient care.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:构建预测慢性心力衰竭患者心脏再同步化治疗(CRT)反应性的列线图,并验证其预测效果。
    方法:进行了一项回顾性研究,包括2018年1月至2022年12月成功接受CRT的109例慢性心力衰竭患者。根据患者术后6个月的CRT术前改善的左室射血分数为5%或至少改善1级NYHA心功能分级,分为有反应组和无反应组。收集患者的临床资料,采用LASSO回归分析和多因素logistic回归分析探讨相关因素。构造了一个列线图,使用校准曲线和决策曲线分析(DCA)评估列线图的预测性能。
    结果:在109例患者中,61人被分配到CRT反应组,48人被分配到无反应组。LASSO回归分析显示左心室收缩末期容积,弥漫性纤维化,左束支传导阻滞(LBBB)是影响心力衰竭患者CRT反应性的独立因素(P<0.05)。基于以上三个预测因素,构造了一个列线图。ROC曲线分析显示曲线下面积(AUC)为0.865(95%CI0.794-0.935)。校准曲线分析表明,列线图的预测概率与实际发生率一致。DCA显示折线图模子具有优越的临床净获益率。
    结论:根据临床特征构建的列线图,实验室,这项研究中的影像学检查在预测慢性心力衰竭患者的CRT反应性方面具有很高的辨别力和校准性。
    OBJECTIVE: To construct a nomogram for predicting the responsiveness of cardiac resynchronization therapy (CRT) in patients with chronic heart failure and verify its predictive efficacy.
    METHODS: A retrospective study was conducted including 109 patients with chronic heart failure who successfully received CRT from January 2018 to December 2022. According to patients after six months of the CRT preoperative improving acuity in the left ventricular ejection fraction is 5% or at least improve grade 1 NYHA heart function classification, divided into responsive group and non-responsive group. Clinical data of patients were collected, and LASSO regression analysis and multivariate logistic regression analysis were used to explore relative factors. A nomogram was constructed, and the predictive performance of the nomogram was evaluated using the calibration curve and decision curve analysis (DCA).
    RESULTS: Among the 109 patients, 61 were assigned to the CRT-responsive group, while 48 were assigned to the non-responsive group. LASSO regression analysis showed that left ventricular end-systolic volume, diffuse fibrosis, and left bundle branch block (LBBB) were independent factors for CRT responsiveness in patients with heart failure (P < 0.05). Based on the above three predictive factors, a nomogram was constructed. The ROC curve analysis showed that the area under the curve (AUC) was 0.865 (95% CI 0.794-0.935). The calibration curve analysis showed that the predicted probability of the nomogram is consistent with the actual occurrence rate. DCA showed that the line graph model has an excellent clinical net benefit rate.
    CONCLUSIONS: The nomogram constructed based on clinical features, laboratory, and imaging examinations in this study has high discrimination and calibration in predicting CRT responsiveness in patients with chronic heart failure.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:贫血是动脉瘤性蛛网膜下腔出血(aSAH)患者的严重且常见的并发症。在贫血发生之前对有风险的患者进行早期干预被认为是潜在有益的,但是没有经过验证的方法可以将患者复杂的临床特征合成为仪器。本研究的目的是开发并外部验证预测aSAH后急性期贫血的列线图。
    方法:我们为aSAH患者开发了一个新的列线图来预测急性期贫血(aSAH发生后3天,出院前)根据人口统计信息,成像,治疗类型,动脉瘤特征,血液检查和临床特征。我们从一个开发队列中设计了模型,并在外部和前瞻性验证队列中测试了列线图。我们纳入了来自第一附属医院的456例aSAH患者,来自三门市人民医院的220人进行外部验证,并进行了前瞻性验证队列,其中包括来自杭州红十字会医院的13名患者。我们通过一致性统计评估了列线图的性能,并根据观察到的贫血发生率评估了预测贫血结果的校准。
    结果:列线图中包含的变量是年龄,治疗方法(开放手术或血管内治疗),基线血红蛋白水平,空腹血糖水平,入院时全身炎症反应综合征评分,格拉斯哥昏迷评分,动脉瘤大小,凝血酶原时间和心率。在验证队列中,急性期贫血预测模型的c统计量为0.910,对预测和报告的贫血结局进行了令人满意的校正(通过眼睛判断).在前瞻性预测中,我们的预测模型获得了84%的成功率,具有一定的临床实用性。
    结论:开发和验证的列线图可用于计算个体化贫血风险,并有可能作为临床医生设计改进的aSAH治疗策略的实用工具。
    BACKGROUND: Anaemia is a severe and common complication in patients with aneurysmal subarachnoid haemorrhage (aSAH). Early intervention for at-risk patients before anaemia occurs is indicated as potentially beneficial, but no validated method synthesises patients\' complicated clinical features into an instrument. The purpose of the current study was to develop and externally validate a nomogram that predicted postacute phase anaemia after aSAH.
    METHODS: We developed a novel nomogram for aSAH patients to predict postacute phase anaemia (3 days after occurrence of aSAH, prior to discharge) on the basis of demographic information, imaging, type of treatment, aneurysm features, blood tests and clinical characteristics. We designed the model from a development cohort and tested the nomogram in external and prospective validation cohorts. We included 456 aSAH patients from The First Affiliated Hospital for the development, 220 from Sanmen People\'s Hospital for external validation and a prospective validation cohort that included 13 patients from Hangzhou Red Cross Hospital. We assessed the performance of the nomogram via concordance statistics and evaluated the calibration of predicted anaemia outcome with observed anaemia occurrence.
    RESULTS: Variables included in the nomogram were age, treatment method (open surgery or endovascular therapy), baseline haemoglobin level, fasting blood glucose level, systemic inflammatory response syndrome score on admission, Glasgow Coma Scale score, aneurysm size, prothrombin time and heart rate. In the validation cohort, the model for prediction of postacute phase anaemia had a c-statistic of 0.910, with satisfactory calibration (judged by eye) for the predicted and reported anaemia outcome. Among forward-looking forecasts, our predictive model achieved an 84% success rate, which showed that it has some clinical practicability.
    CONCLUSIONS: The developed and validated nomogram can be used to calculate individualised anaemia risk and has the potential to serve as a practical tool for clinicians in devising improved treatment strategies for aSAH.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    由于过去几十年来诊断和治疗方法的进步,越来越多的早期肝细胞癌(HCC)诊断使更多比例的患者能够接受治愈性治疗.然而,早期复发的高风险和不良预后仍然是HCC治疗的主要挑战.微血管侵犯(MVI)已被证明是治愈性治疗后早期复发的重要独立预测因素。目前,由于抽样误差和活检后肿瘤细胞接种的高风险,通常不建议在治疗前进行活检以根据临床指南评估HCC中的MVI。因此,术后组织病理学检查是公认的MVI诊断的金标准,但这一滞后指标极大地阻碍了临床医生为预后选择最佳有效治疗方法.由于成像现在可以无创和完全评估整个肿瘤和宿主的情况,在MVI的术前评估中发挥着越来越重要的作用。因此,MVI诊断的影像学标准对于优化个性化治疗决策和实现更好的预后非常理想.在这次审查中,我们总结了用于预测MVI的不同成像方式的新兴图像特征。我们还讨论了成像技术的进步是否已经产生了可以改变实践的证据,以及先进的成像技术是否会彻底改变早期HCC的治疗决策。
    Owing to advances in diagnosis and treatment methods over past decades, a growing number of early-stage hepatocellular carcinoma (HCC) diagnoses has enabled a greater of proportion of patients to receive curative treatment. However, a high risk of early recurrence and poor prognosis remain major challenges in HCC therapy. Microvascular invasion (MVI) has been demonstrated to be an essential independent predictor of early recurrence after curative therapy. Currently, biopsy is not generally recommended before treatment to evaluate MVI in HCC according clinical guidelines due to sampling error and the high risk of tumor cell seeding following biopsy. Therefore, the postoperative histopathological examination is recognized as the gold standard of MVI diagnosis, but this lagging indicator greatly impedes clinicians in selecting the optimal effective treatment for prognosis. As imaging can now noninvasively and completely assess the whole tumor and host situation, it is playing an increasingly important role in the preoperative assessment of MVI. Therefore, imaging criteria for MVI diagnosis would be highly desirable for optimizing individualized therapeutic decision-making and achieving a better prognosis. In this review, we summarize the emerging image characteristics of different imaging modalities for predicting MVI. We also discuss whether advances in imaging technique have generated evidence that could be practice-changing and whether advanced imaging techniques will revolutionize therapeutic decision-making of early-stage HCC.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:本系统综述旨在帮助临床决策,为困难的气管插管选择合适的术前预测方法,通过识别和综合有关接受所有类型手术的成年患者的这些方法的文献。
    方法:按照PRISMA指南进行系统评价和荟萃分析。2023年3月28日完成了跨多个数据库的全面电子搜索。两名研究人员独立筛选,选定的研究,并提取数据。共纳入227篇文章,代表526项研究,并使用QUADAS-2工具评估偏倚。元光盘软件计算合并灵敏度(SEN),特异性(SPC),正似然比(PLR),负似然比(NLR),和诊断比值比(DOR)。使用Spearman相关系数评估异质性,Cochran\'s-Q,和I2指数,利用元回归探索异质性来源。使用Deeks漏斗图评估出版偏倚。
    结果:在检索到的2906篇文章中,227符合纳入标准,包括总共686,089名患者。该综述检查了11种预测气管插管困难的方法,分为体格检查,多元评分系统,和成像测试。改良的Mallampati测试(MMT)显示SEN为0.39,SPC为0.86,而甲状腺距离(TMD)的SEN为0.38,SPC为0.83。上唇咬伤测试(ULBT)的SEN为0.52,SPC为0.84。多变量评分系统如LEMON和Wilson的风险评分显示出中等的敏感性和特异性。成像测试,特别是基于超声的方法,如从皮肤到会厌的距离(US-DSE),表现出更高的敏感性(0.80)和特异性(0.77)。在研究中发现了显著的异质性,受样本量和研究设计等因素的影响。
    结论:没有单一的术前预测方法在预测气管插管困难方面具有明显的优越性。证据支持使用针对特定患者人口统计学和临床背景量身定制的多种方法的组合方法。未来的研究应该集中在整合人工智能和深度学习等先进技术,以改进预测模型。标准化测试程序和建立明确的截止值对于提高预测的可靠性和准确性至关重要。实施多模式预测方法可以减少意想不到的困难插管,改善患者安全和预后。
    BACKGROUND: This systematic review aims to assist clinical decision-making in selecting appropriate preoperative prediction methods for difficult tracheal intubation by identifying and synthesizing literature on these methods in adult patients undergoing all types of surgery.
    METHODS: A systematic review and meta-analysis were conducted following PRISMA guidelines. Comprehensive electronic searches across multiple databases were completed on March 28, 2023. Two researchers independently screened, selected studies, and extracted data. A total of 227 articles representing 526 studies were included and evaluated for bias using the QUADAS-2 tool. Meta-Disc software computed pooled sensitivity (SEN), specificity (SPC), positive likelihood ratio (PLR), negative likelihood ratio (NLR), and diagnostic odds ratio (DOR). Heterogeneity was assessed using the Spearman correlation coefficient, Cochran\'s-Q, and I2 index, with meta-regression exploring sources of heterogeneity. Publication bias was evaluated using Deeks\' funnel plot.
    RESULTS: Out of 2906 articles retrieved, 227 met the inclusion criteria, encompassing a total of 686,089 patients. The review examined 11 methods for predicting difficult tracheal intubation, categorized into physical examination, multivariate scoring system, and imaging test. The modified Mallampati test (MMT) showed a SEN of 0.39 and SPC of 0.86, while the thyromental distance (TMD) had a SEN of 0.38 and SPC of 0.83. The upper lip bite test (ULBT) presented a SEN of 0.52 and SPC of 0.84. Multivariate scoring systems like LEMON and Wilson\'s risk score demonstrated moderate sensitivity and specificity. Imaging tests, particularly ultrasound-based methods such as the distance from the skin to the epiglottis (US-DSE), exhibited higher sensitivity (0.80) and specificity (0.77). Significant heterogeneity was identified across studies, influenced by factors such as sample size and study design.
    CONCLUSIONS: No single preoperative prediction method shows clear superiority for predicting difficult tracheal intubation. The evidence supports a combined approach using multiple methods tailored to specific patient demographics and clinical contexts. Future research should focus on integrating advanced technologies like artificial intelligence and deep learning to improve predictive models. Standardizing testing procedures and establishing clear cut-off values are essential for enhancing prediction reliability and accuracy. Implementing a multi-modal predictive approach may reduce unanticipated difficult intubations, improving patient safety and outcomes.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号